Research Article | Open Access
Zhuyun Liu, Alan Kelleher, Shanii Tabb, Junfei Wei, Jeroen Pollet, Peter J. Hotez, Maria Elena Bottazzi, Bin Zhan, Oluwatoyin A. Asojo, "Identification, Characterization, and Structure of Tm16 from Trichuris muris", Journal of Parasitology Research, vol. 2017, Article ID 4342789, 10 pages, 2017. https://doi.org/10.1155/2017/4342789
Identification, Characterization, and Structure of Tm16 from Trichuris muris
Trichuriasis is a disease of poverty for which excretory and secretory (ES) products that induce the protective immunity are being investigated as candidate vaccines antigens. In this study, ES products of T. muris and immune sera were produced. The immune sera recognized more than 20 proteins on a 2D-gel of ES products of T. muris adult worms. Tm16 was one of the proteins identified by mass spectrometry. Tm16 shares 57% sequence identity with Ov16, an immunodominant diagnostic antigen from Onchocerca volvulus. Recombinant Tm16 with a carboxyl terminal hexahistidine was produced using Pichia pastoris. Polyclonal antibodies against rTm16 were generated by one-prime and two-boost immunization of three female Balb/c mice with 25 μg of recombinant Tm16 emulsified with ISA720 adjuvant. These polyclonal antibodies confirmed that Tm16 is localized to the ES products and the soluble fraction of the adult worm. Additionally, the high-resolution crystal structure of Tm16 was solved by molecular replacement. Tm16 belongs to the phosphatidylethanolamine-binding-like protein (PEBP1) family and this is the first structure of a PEBP1 from a parasite.
Trichuris trichiura, one of the three most common soil-transmitted nematodes, causes trichuriasis in more than 450 million people and an estimated 544,000 disability adjusted life years globally according to the Global Burden of Disease Study 2015 . Trichuriasis remains a problem in the USA, with 13% of school children in Clay County, Kentucky, infested with Trichuris trichiura [2–4]. Trichuriasis is also a health concern for the poor in rural areas of the gulf coast, Appalachia, tribal lands, and inner cities, and for refugee communities, prisoners, mental health patients, migrant workers, and children in all parts of the country who are allowed to play in soil or sand that could be contaminated [3, 4]. The current approaches for soil-transmitted helminth infections such as trichuriasis include mass drug administration, but the major drugs (mebendazole, albendazole) used to treat trichuriasis have a low (28–36%) cure rate  and do not completely break the cycle of reinfection . This observation explains why the global prevalence of human whipworm infection has decreased only 2.1% over the last decade , such that there is a vital need for alternative therapies that ameliorate the health of infected people in order to alleviate the global health and economic and social burdens of NTDs. Currently, trichuriasis is diagnosed using fecal egg counts and there is a need to develop additional diagnostic methods.
One possible approach is to identify diagnostics or vaccine antigens for T. trichiura using the mouse equivalent, Trichuris muris, as a model. Like T. trichiura, T. muris is a whipworm with a long and narrow head embedding in the epithelial layer of large intestine of the host. There is precedence for characterizing ES products as candidate vaccine antigens for parasites. ES products are known to suppress host immune response and facilitate parasitism in the hostile environment of the host [7, 8]. Mice immunized with some ES products produced almost sterile protective immunity against challenge of T. muris infective eggs [7, 8]. Our vaccine discovery efforts include the identification and characterization of ES products that induce the protective immunity as vaccine candidates. We present here the identification, production, and crystal structure of Tm16, a whipworm ES protein. Tm16 shares 57% amino acid identity with Ov16, an immunodominant diagnostic antigen of Onchocerca volvulus. Ov16 was identified from sera of West African Onchocerciasis patients and determined to be a selective antigen that is recognized only by sera from people infected with Onchocerca volvulus, but not people infected with other filarial parasites .
Based on its amino acid sequence, Tm16 belongs to the PEBP and DOCK1 superfamily. PEBP is highly conserved in organisms including bacteria, yeast, nematodes, plants, drosophila, and mammals  with functions involved in the control of several signaling pathways by interacting with other cellular components including the inhibition of the MAP kinase pathway , the NF-B pathway , regulation of the action of heterotrimeric G proteins , and serine protease inhibition . PEBP also acts as a kinase regulator controlling the morphological switch between shoot growth and flower structures . DOCK1 (also called DOCK180) coordinates with ELMO1 to regulate the small GTPase Rac, thereby influencing several biological processes, including phagocytosis, cell migration, and signal pathway. Dock1 in Caenorhabditis elegans plays a critical role in Rac-dependent cell migration that is essential throughout the embryonic and adult life of the nematode . DOCK180 is an effector molecule which transduces signals from tyrosine kinases through the CRK adaptor protein . Farnesylated DOCK180 can drive cell spreading, implying that it is involved in the regulation of cell movement by tyrosine kinases. Some research suggested DOCK1-like protein was involved in the cytoskeletal reorganization required for an engulfing cell to extend its surface around a dying cell during phagocytosis .
2. Materials and Methods
2.1. Production of Excretory and Secretory (ES) Products of T. muris and Immune Sera
ES products were produced using established protocols [18–25]. ES products were obtained from the overnight culture of T. muris adult worms isolated from laboratory maintained STAT6/KO mice. The concentrated T. muris ES products were used to immunize AKR mice, generate antisera, and test vaccine efficacy against T. muris infection. Each mouse was subcutaneously immunized with 100 μg ES products formulated with ISA720 (Seppic, France) three times with 2-week interval. The antisera (mouse anti-ES sera) were obtained from immunized mice 10 days after the last immunization and the immunized mice were subsequently challenged with 300 T. muris embryonated eggs.
2.2. Electrophoresis and Immunoblotting of ES Products
The anti-ES sera were collected from mice immunized with T. muris ES products. The mouse anti-ES sera were used to identify ES products separated on a 2D gel as previously described . Briefly, 100 μg/600 μg of T. muris ES products were separated on two 2D gels. The gel loaded with 100 μg of T. muris ES products was transferred on a PVDF membrane, while that loaded with 600 μg of T. muris ES products was stained with Coomassie brilliant blue. The spots were recognized by Western blotting using mouse anti-ES immune sera as primary antibody and HRP-conjugated anti-mouse IgG (Invitrogen, US, 1 : 5,000) as secondary antibody. Spots were visualized by ECL chemiluminescence (Thermo Scientific, US). There were more than 20 protein spots recognized by the immune sera. Ten of the corresponding proteins of the recognized spots on the Coomassie-stained gel were identified by matching with immunoblot image and excised.
2.3. Protein Identification and Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Ten spots were excised from the 2D-PAGE gel of the ES products and sent to Keck Biotechnology Resource Laboratory at Yale University for protein identification using liquid chromatography with tandem mass spectrometry (LC-MS/MS). Once received at Keck Biotechnology Center, spots were washed with 50% acetonitrile for 10 min with rocking and then washed with 50% acetonitrile/50 mM NH4HCO3. After a final wash with 50% acetonitrile/10 mM NH4HCO3, the gel spots were dried by speed vacuum. Each spot was resuspended in 35 μl of 10 mM NH4HCO3, containing 0.25 μg of digestion grade trypsin (Promega, V5111), and incubated at 37°C for 14 hours.
LC-MS/MS analysis was performed on a Thermo Scientific Orbitrap Elite equipped with a Waters nanoAcquity UPLC system utilizing a binary solvent system (Buffer A: 100% water, 0.1% formic acid; Buffer B: 100% acetonitrile, 0.1% formic acid). Trapping was performed at 5 μl/min, 97% Buffer A for 3 min using a Waters Symmetry® C18 180 μm × 20 mm trap column. Peptides were separated using an ACQUITY UPLC PST (BEH) C18 nanoACQUITY Column 1.7 μm, 75 μm × 250 mm (37°C) and eluted at 300 nl/min with the following gradient: 3% buffer B at initial conditions; 10% B at 1 minute; 35% B at 38 minutes; 90% B at 43 minutes; 90% B at 48 min; return to initial conditions at 50 minutes. MS was acquired in the Orbitrap in profile mode over the 300–1,800 range using 1 microscan, 30,000 resolution, AGC target of 1E6, and a full max ion time of 50 ms. Up to 15 MS/MS were collected per MS scan on species reaching an intensity threshold of 3,000 (charge states one and above). Data dependent MS/MS were acquired in centroid mode in the ion trap using 1 microscan, 15,000 resolution, AGC target of 2E4, full max IT of 100 ms, 2.0 isolation window, and CID fragmentation with a normalized collision energy of 35. Dynamic exclusion was enabled with a repeat count of 1, repeat duration of 30 s, exclusion list size of 500, and exclusion duration of 60 s.
Data were searched in-house using the Mascot algorithm (Matrix Science; version 2.5.1) for uninterpreted MS/MS spectra after using the Mascot Distiller program to generate peak lists. The data was searched against an NCBInr database. Search parameters used were trypsin digestion with up to 2 missed cleavages; peptide mass tolerance of 10 ppm; MS/MS fragment tolerance of +0.5 Da; and variable modifications of Met oxidation and propionamide adduct to Cys. Normal and decoy database searches were searched to determine the false discovery rate, with the confidence level set to 95% ().
2.4. Production of Recombinant Tm16 Protein
DNA encoding the full length Tm16 was amplified from the total first-strand cDNA of adult T. muris and cloned into the Pichia pastoris expression vector pPICZαA (Invitrogen, USA), using the EcoRI and NotI restriction sites to add a C-terminal hexahistidine tag. The correct open reading frame (ORF) was confirmed by sequencing using the vector flanking primers corresponding to the regions encoding the α-factor and 3′AOX1 genes. The recombinant plasmids were linearized following digestion with SacI and transformed into P. pastoris X33 strain by electroporation. A single colony was selected from zeocin-resistant YPD plates and recombinant Tm16 protein (rTm16) expression was induced in media containing 0.5% methanol for 72 hours. The culture supernatant containing the secreted rTm16 was isolated by centrifugation and filtered with 0.22 μm PES filter top. The rTm16 was purified by Ni immobilized metal affinity chromatography (IMAC) and eluting with an imidazole gradient in the same buffer. The purified protein was dialyzed against TBS pH 7.5 to remove imidazole, concentrated to 1.6 mg/ml, and stored at −80°C.
2.5. Crystallization, Data Collection, and Structure Determination
The rTm16 was crystallized as flat plates at 289 K using vapor diffusion. Sitting drop contained 1.5 μL of 22 mg/ml rTm16 in 5 mM Bis(2-hydroxyethyl)aminotris(hydroxymethyl) methane pH 6.5 and 1.5 μL of the precipitant solution (0.1 M HEPES pH 7.5, 10% (v/v) isopropanol, 20% (w/v) PEG 4000), while the reservoir contained 300 μL of precipitant solution. Crystals of dimension 0.2 mm × 0.05 mm × 0.5 mm (Figure S.1 in Supplementary Material, available online at https://doi.org/10.1155/2017/4342789) grew within 48 hours and the largest of these crystals diffracted to ~1.7 Å on the home source.
Crystals were flash-cooled directly in a stream of N2 gas at 113 K prior to collecting diffraction data at the Baylor College of Medicine core facility (Rigaku HTC detector, Rigaku FR-E+ SuperBright microfocus rotating anode generator, with VariMax HF optics) using the Crystal Clear (trek) package . Data was integrated using MosFLM and scaled with SCALA . Data collection and processing statistics are summarized in Table 1.
|Statistics for the highest-resolution shell are shown in parentheses. Estimated = Rmerge, where is data multiplicity.|
Tm16 structure was solved by molecular replacement (MR) using PHASER [29, 30] with the crystal structure of human phosphatidylethanolamine-binding protein pdb code 1BEH  stripped of all ligands and Waters as search model. The deposited model was obtained by model building with Coot  and structure refinement with PHENIX . Structural figures were generated using PyMOL . Structure solution and refinement statistics are summarized in Table 1. Quality of the electron density maps is illustrated in Figure S.2.
2.6. Size-Exclusion Chromatography and Multiangle Light Scattering (SECMALS)
The rTm16 was concentrated and buffer exchanged to 15 mg/ml in PBS using a 10 kDA cut-off filter (Amicon Ultra-0.5 mL Centrifugal Filters). 25 μL of rTm16 was injected onto a Phenomenex Yarra 3 μm SEC-2000 column (Phenomenex, Torrance, CA) at flow-rate of 0.5 ml/min using an Agilent 1260 Infinity series HPLC. The mobile phase was PBS buffer at pH 7.4. The elution was detected with a UV detector (Agilent), a miniDAWN triple-angle light scattering detector (Wyatt Technology), and an Optilab rEX differential refractometer (Wyatt Technology) connected in series. The protein concentration was monitored across the peak using the protein extinction coefficient at 280 nm. The isotropic scatterer for detector normalization was bovine serum albumin. Molecular mass was calculated from the light scattering and interferometric refractometer data using ASTRA 6.1 software.
2.7. Generation of Mouse Antiserum and Western Blotting
For generating polyclonal antibodies against Tm16, three female Balb/c mice were subcutaneously immunized with 25 μg of recombinant Tm16 (rTm16) emulsified with ISA720 adjuvant (Seppic, France), followed by two boosts at 3-week intervals. Fourteen days after the last boost, the mice were euthanized, their blood was collected, and sera was isolated and pooled. The resulting mouse anti-rTm16 sera was aliquoted and stored at −20°C. The localization of native Tm16 in T. muris adult ES products was determined by Western blotting using mouse anti-rTm16 sera. Total 5.0–10.0 μg of T. muris adult ES was separated on a precast 4–20% gradient SDS polyacrylamide gel (Invitrogen) transferred onto a PVDF membrane (Millipore). The native Tm16 was probed with a 1 : 4000 dilution of mouse anti-Tm16 sera and visualized with HRP-conjugated anti-mouse IgG (Invitrogen, US, 1 : 5,000) and ECL chemiluminescence (Thermo scientific, US). 50 ng of rTm16 and rTm14-3-3, another recombinant T. muris protein, were used as positive and negative control, respectively.
2.8. Phylogenetic Tree Generation
The phylogenetic tree was generated using one click analysis mode online at http://www.phylogeny.fr. MUSCLE 3.8.31 was used for multiple sequence alignment while PhyML 3.1 for phylogeny and TreeDyn 198.3 was used for tree rendering.
3.1. Identification of Tm16
The T. muris excreted products were separated on 2D gel and visualized with Coomassie staining (Figure 1(a)) or probed with mouse anti-ES immune sera (Figure 1(b)). The Coomassie-stained gel and immunoblot gel were aligned and matched. Ten of the overlapped spots were excised for protein identification by mass spectrometry (MS). Through a BLAST search against the GenBank database, a 187 amino acid protein sharing 57% amino acid identity with Ov16, an immunodominant antigen of Onchocerca volvulus , and 86% identity with Tt16 from human T. trichiura (CDW60800.1) was identified and named Tm16. The major proteins identified by MS are detailed in Table 2.
Tm16 was identified in spots 9 and 7 which are written in bold in Table 2. The confidence scores for the identification of each peptide from the Tm16 protein provided by MASCOT are provided in Table 3 as evidence for the identification of the protein in each separated spot.
Phylogenetic tree comparison of Tm16 reveals that it belongs to the same branch as Ov16 (Figure 2). Tm16 belongs to the phosphatidylethanolamine-binding-like protein (PEBP) and dedicator of cytokinesis protein 1 (DOCK1) superfamily (Figure 2). The PEBP superfamily is highly conserved in organisms including bacteria, yeast, nematodes, plants, drosophila, and mammals . PEBP are involved in the control of several signaling pathways by interacting with other cellular components including the inhibition of the MAP kinase pathway , the NF-B pathway , regulation of the action of heterotrimeric G proteins , and serine protease inhibition  and acting as a kinase regulator controlling the morphological switch between shoot growth and flower structures .
3.2. Production of rTm16 and Native Tm16 Localization
rTm16 is highly expressed as soluble protein in yeast Pichia pastoris X-33 by methanol induction and could be purified to ~99% purity by IMAC (Figure 3(a)). Antiserum generated against rTm16 (mouse anti-rTm16) was specific enough to determine the localization of native Tm16 in T. muris worms by Western blotting and demonstrated that native Tm16 is localized in the T. muris adult ES products (Figure 3(b)). Mouse anti-rTm16 was also specific for Tm16 and does not recognize another recombinant hexahistidine tagged T. muris antigen Tm-14-3-3 (Figure 3(b)). The recombinant Tm16 appeared as ~1 kDa higher than native Tm16 since rTm16 contains a hexahistidine tag expressed at C-terminus.
3.3. Structure of Tm16
The structure of Tm16 solved by molecular replacement has a monomer in the asymmetric unit. Like the crystal structure, rTm16 is monomeric in solution and the solution molecular mass determined by SECMALS is ~21.4 kDa (Figure 4(a)). The atomic coordinate and structure factors have been deposited in the protein data bank under accession number 5TVD. Tm16 has the typical topology of a phosphatidylethanolamine-binding-like protein (PEBP), having four helices and nine beta strands that include the central six-strand beta sheet of the PEBP fold (Figure 4(b)). A large central cavity corresponding to the putative PEBP ligand-binding pocket is located at the end of the central beta sheet (Figures 4(c) and 4(d)).
The structures most similar to Tm16 were identified by 3D structural alignment using PDBeFold’s structure similarity option (http://www.ebi.ac.uk/msd-srv/ssm/) and the most similar structure was the human phosphatidylethanolamine-binding-like protein (hPEBP)  followed by homologues from other mammals. The main chain atoms of the Tm16 monomers align with hPEBP with an rmsd of 0.456 Å for all main chain atoms (Figure 5(a)). Additionally, the putative binding cavity of Tm16 also aligns well with that of hPEBP with sufficient space to accommodate ligands (Figure 5(b)). The structure of Tm16 can serve as a suitable model to predict the structure of other parasite phosphatidylethanolamine-binding-like proteins based on predicted topology and sequence conservation (Figure 5(c)).
The crystal structure of Tm16 is the first structure of a parasite PEBP and reveals a prototypical phosphatidylethanolamine-binding-like topology with a large binding cavity capable of accommodating various ligands and suggestive of the ability to bind with macromolecules related to the signal pathway and transduction or cell migration and regulation (Figures 4 and 5). Since Tm16 shares extensive structural similarity with hPEBP, it may have similar functions.
Given that Tm16 is one of the T. muris secreted proteins that induce protective immunity in immunized mice, it can be investigated as a putative vaccine candidate for preventing Trichuris infection. The high yield expression of Tm16 as a soluble recombinant protein in a scalable reproducible P. pastoris system is the first step towards developing it as a vaccine candidate for vaccine trial using our T. muris mouse model. Due to the similarity of Tm16 to Ov16 it may instead be more suitable as a diagnostic antigen. More studies are required to determine if Tm16 functions as a biofunctional PEBP/DOCK1 regulatory molecule and what effects these putative functions have on future applications of Tm16.
Tm16 was identified as part of antigen discovery efforts, and methods were developed for the production and purification of Tm16. Its similarity to Ov16 makes it a promising diagnostic antigen. The recombinant protein produced was monodisperse and pure and was used for structure determination. Tm16 is the first structure of a parasite PEBP and reveals significant structural similarity to mammalian PEBP. The roles of Tm16 in the survival of parasite in host, the pathobiology of human trichuriasis, and host-parasite interactions based on its putative functions in ligand binding and cell signaling are topics for future investigation.
The atomic coordinate and structure factors have been deposited in the protein data bank under accession number 5TVD.
Conflicts of Interest
The authors have no conflicts of interest to declare.
Oluwatoyin A. Asojo and Bin Zhan conceived the studies and interpreted the results. Zhuyun Liu produced proteins and performed ESP studies. Junfei Wei produced ES and performed cloning experiments. Jeroen Pollet performed SECMALS and analysed SECMALS results. Shanii Tabb and Alan Kelleher identified and optimized the protein crystallization process. Oluwatoyin A. Asojo collected crystallographic data and solved crystal structure. Bin Zhan and Oluwatoyin A. Asojo wrote the first draft of the manuscript. Peter J. Hotez and Maria Elena Bottazzi helped conceive the Trichuriasis project. All authors approved the final manuscript.
The authors thank Drs. Jean Kanyo and Tukiet Lam of the Mass Spectrometry and Protein Chemistry Facility of the W. M. Keck Biotechnology Resource Laboratory at Yale University for LC MS/MS and Mascot analysis. They thank the vaccine discovery center at the National School of Tropical Medicine at the Baylor College of Medicine for funding these studies. They thank Nathaniel Wolf for editorial guidance. They thank Dr. Sukyeong Lee for access to BCM X-ray facility and Dr. Mitchell L. Miller for access to Rice Univerity X-ray facility for crystal screening. They thank Elissa M. Hudspeth, Fernanda Lugo, Selam Gebremedhin, and Nathan Heffernan for working with Shanii Tabb during the summer. Shanii Tabb was supported by an American Chemical Society Project SEED fellowship for high school students.
Figure S.1: Sample crystals of Tm16.
Figure S.2: Fit of Tm16 in 2Fo-Fc Electron density maps contoured at 1.6sigma.
- G. B. D. DALYs and H. Collaborators, “Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015, Lancet, 388 (2016) 1603–1658”.
- P. J. Hotez, P. J. Brindley, J. M. Bethony, C. H. King, E. J. Pearce, and J. Jacobson, “Helminth infections: the great neglected tropical diseases,” Journal of Clinical Investigation, vol. 118, no. 4, pp. 1311–1321, 2008.
- S. Knopp, P. Steinmann, C. Hatz, J. Keiser, and J. Utzinger, “Nematode infections: filariases,” Infectious Disease Clinics of North America, vol. 26, no. 2, pp. 359–381, 2012.
- S. Knopp, P. Steinmann, J. Keiser, and J. Utzinger, “Nematode infections: soil-transmitted helminths and trichinella,” Infectious Disease Clinics of North America, vol. 26, no. 2, pp. 341–358, 2012.
- J. Keiser and J. Utzinger, “Efficacy of current drugs against soil-transmitted helminth infections: Systematic review and meta-analysis,” JAMA - Journal of the American Medical Association, vol. 299, no. 16, pp. 1937–1948, 2008.
- W. Beck and J. E. Davies, Medical Parasitology, Mosby Company, London, Engalnd, Third Edition edition, 1981.
- H. Dixon, C. E. Johnston, and K. J. Else, “Antigen selection for future anti-Trichuris vaccines: a comparison of cytokine and antibody responses to larval and adult antigen in a primary infection,” Parasite Immunology, vol. 30, no. 9, pp. 454–461, 2008.
- H. Dixon, M. C. Little, and K. J. Else, “Characterisation of the protective immune response following subcutaneous vaccination of susceptible mice against Trichuris muris,” International Journal for Parasitology, vol. 40, no. 6, pp. 683–693, 2010.
- E. Lobos, M. Altmann, G. Mengod, N. Weiss, W. Rudin, and M. Karam, “Identification of an Onchocerca volvulus cDNA encoding a low-molecular-weight antigen uniquely recognized by onchocerciasis patient sera,” Molecular and Biochemical Parasitology, vol. 39, no. 1, pp. 135–145, 1990.
- K. Yeung, T. Seitz, S. Li et al., “Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP,” Nature, vol. 401, no. 6749, pp. 173–177, 1999.
- K. C. Yeung, D. W. Rose, A. S. Dhillon et al., “Raf kinase inhibitor protein interacts with NF-κB-inducing kinase and TAK1 and inhibits NF-κB activation,” Molecular and Cellular Biology, vol. 21, no. 21, pp. 7207–7217, 2001.
- T. Kroslak, T. Koch, E. Kahl, and V. Höllt, “Human Phosphatidylethanolamine-binding Protein Facilitates Heterotrimeric G Protein-dependent Signaling,” Journal of Biological Chemistry, vol. 276, no. 43, pp. 39772–39778, 2001.
- U. Hengst, H. Albrecht, D. Hess, and D. Monard, “The phosphatidylethanolamine-binding protein is the prototype of a novel family of serine protease inhibitors,” Journal of Biological Chemistry, vol. 276, no. 1, pp. 535–540, 2001.
- M. J. Banfield and R. L. Brady, “The structure of Antirrhinum centroradialis protein (CEN) suggests a role as a kinase regulator,” Journal of Molecular Biology, vol. 297, no. 5, pp. 1159–1170, 2000.
- C. M. Grimsley, J. M. Kinchen, A.-C. Tosello-Trampont et al., “Dock180 and ELMO1 proteins cooperate to promote evolutionarily conserved rac-dependent cell migration,” Journal of Biological Chemistry, vol. 279, no. 7, pp. 6087–6097, 2004.
- H. Hasegawa, E. Kiyokawa, S. Tanaka et al., “DOCK180, a major CRK-binding protein, alters cell morphology upon translocation to the cell membrane,” Molecular and Cellular Biology, vol. 16, no. 4, pp. 1770–1776, 1996.
- M. R. S. Erickson, B. J. Galletta, and S. M. Abmayr, “Drosophila myoblast city encodes a conserved protein that is essential for myoblast fusion, dorsal closure, and cytoskeletal organization,” Journal of Cell Biology, vol. 138, no. 3, pp. 589–603, 1997.
- X. Yang, Y. Yang, Y. Wang et al., “Excretory/secretory products from Trichinella spiralis adult worms ameliorate DSS-induced colitis in mice,” PLoS ONE, vol. 9, no. 5, Article ID e96454, 2014.
- X. Bai, X. Wu, X. Wang et al., “Regulation of cytokine expression in murine macrophages stimulated by excretory/secretory products from Trichinella spiralis in vitro,” Molecular and Cellular Biochemistry, vol. 360, no. 1-2, pp. 79–88, 2012.
- M. Langelaar, C. Aranzamendi, F. Franssen et al., “Suppression of dendritic cell maturation by Trichinella spiralis excretory/secretory products,” Parasite Immunology, vol. 31, no. 10, pp. 641–645, 2009.
- H. M. Lun, C. H. Mak, and R. C. Ko, “Characterization and cloning of metallo-proteinase in the excretory/secretory products of the infective-stage larva of Trichinella spiralis,” Parasitology Research, vol. 90, no. 1, pp. 27–37, 2003.
- C.-H. Mak and R. C. Ko, “Characterization of endonuclease activity from excretory/secretory products of a parasitic nematode, Trichinella spiralis,” European Journal of Biochemistry, vol. 260, no. 2, pp. 477–481, 1999.
- V. K. Todorova and M. W. Kennedy, “Proteinases in the excretory/secretory products (ES) of adult Trichinella spiralis,” Parasitology, vol. 111, no. 2, pp. 201–208, 1995.
- R. C. Ko and L. Fan, “Changes in host muscles induced by excretory/secretory products of larval Trichinella spiralis and Trichinella pseudospiralis,” Parasitology, vol. 108, no. 2, pp. 195–205, 1994.
- R. C. Ko, L. Fan, and D. L. Lee, “Experimental reorganization of host muscle cells by excretory/secretory products of infective trichinella spiralis larvae,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 86, no. 1, pp. 77-78, 1992.
- J. Yang, W. Pan, X. Sun et al., “Immunoproteomic profile of Trichinella spiralis adult worm proteins recognized by early infection sera,” Parasites and Vectors, vol. 8, no. 1, article no. 20, 2015.
- J. W. Pflugrath, “The finer things in X-ray diffraction data collection,” Acta Crystallographica Section D: Biological Crystallography, vol. 55, no. 10, pp. 1718–1725, 1999.
- A. G. W. Leslie, “The integration of macromolecular diffraction data,” Acta Crystallographica Section D: Biological Crystallography, vol. 62, no. 1, pp. 48–57, 2006.
- A. J. McCoy, R. W. Grosse-Kunstleve, L. C. Storoni, and R. J. Read, “Likelihood-enhanced fast translation functions,” Acta Crystallographica Section D: Biological Crystallography, vol. 61, no. 4, pp. 458–464, 2005.
- L. C. Storoni, A. J. McCoy, and R. J. Read, “Likelihood-enhanced fast rotation functions,” Acta Crystallographica Section D: Biological Crystallography, vol. 60, no. 3, pp. 432–438, 2004.
- M. J. Banfield, J. J. Barker, A. C. F. Perry, and R. L. Brady, “Function from structure? The crystal structure of human phosphatidylethanolamine-binding protein suggests a role in membrane signal transduction,” Structure, vol. 6, no. 10, pp. 1245–1254, 1998.
- P. Emsley, B. Lohkamp, W. G. Scott, and K. Cowtan, “Features and development of Coot,” Acta Crystallographica Section D: Biological Crystallography, vol. 66, no. 4, pp. 486–501, 2010.
- P. D. Adams, P. V. Afonine, G. Bunkóczi et al., “PHENIX: a comprehensive Python-based system for macromolecular structure solution,” Acta Crystallographica D: Biological Crystallography, vol. 66, part 2, pp. 213–221, 2010.
- W. L. Delano, The PyMOL Molecular Graphics System http://www.pymol.org, (2002).
- P. Gouet, X. Robert, and E. Courcelle, “ESPript/ENDscript: extracting and rendering sequence and 3D information from atomic structures of proteins,” Nucleic Acids Research, vol. 31, no. 13, pp. 3320–3323, 2003.
- P. Gouet, E. Courcelle, D. I. Stuart, and F. Métoz, “ESPript: analysis of multiple sequence alignments in PostScript,” Bioinformatics, vol. 15, no. 4, pp. 305–308, 1999.
Copyright © 2017 Zhuyun Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.